Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 2
2008 2
2009 1
2010 1
2013 1
2014 1
2016 1
2017 3
2018 1
2019 2
2020 5
2021 5
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Ectopic fat accumulation and metabolic syndrome.
Rasouli N, Molavi B, Elbein SC, Kern PA. Rasouli N, et al. Diabetes Obes Metab. 2007 Jan;9(1):1-10. doi: 10.1111/j.1463-1326.2006.00590.x. Diabetes Obes Metab. 2007. PMID: 17199713 Review.
Allosteric Inhibition of a Mammalian Lectin.
Aretz J, Anumala UR, Fuchsberger FF, Molavi N, Ziebart N, Zhang H, Nazaré M, Rademacher C. Aretz J, et al. J Am Chem Soc. 2018 Nov 7;140(44):14915-14925. doi: 10.1021/jacs.8b08644. Epub 2018 Oct 24. J Am Chem Soc. 2018. PMID: 30303367
To overcome the supposedly poor druggability of C-type lectin receptors and to identify starting points for chemical probe development, we screened murine langerin using (1)H and (19)F NMR against a library of 871 drug-like fragments. Subsequently, hits were validated by s …
To overcome the supposedly poor druggability of C-type lectin receptors and to identify starting points for chemical probe development, we s …
T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses.
Aleebrahim-Dehkordi E, Molavi B, Mokhtari M, Deravi N, Fathi M, Fazel T, Mohebalizadeh M, Koochaki P, Shobeiri P, Hasanpour-Dehkordi A. Aleebrahim-Dehkordi E, et al. Transpl Immunol. 2022 Feb;70:101495. doi: 10.1016/j.trim.2021.101495. Epub 2021 Nov 10. Transpl Immunol. 2022. PMID: 34774738 Free PMC article. Review.
Cytokines produced by T helper cells (T(h) cells) have essential roles in the body's defense against viruses. ...
Cytokines produced by T helper cells (T(h) cells) have essential roles in the body's defense against viruses. ...
Signal Change in the Mammillary Bodies after Perinatal Asphyxia.
Molavi M, Vann SD, de Vries LS, Groenendaal F, Lequin M. Molavi M, et al. AJNR Am J Neuroradiol. 2019 Nov;40(11):1829-1834. doi: 10.3174/ajnr.A6232. Epub 2019 Nov 6. AJNR Am J Neuroradiol. 2019. PMID: 31694818 Free PMC article.
99mTc(CO)3-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-HT7 receptors.
Mardanshahi A, Vaseghi S, Hosseinimehr SJ, Abedi SM, Molavipordanjani S. Mardanshahi A, et al. Ann Nucl Med. 2024 Feb;38(2):139-153. doi: 10.1007/s12149-023-01885-2. Epub 2023 Nov 30. Ann Nucl Med. 2024. PMID: 38032496
METHODS: Compounds 6 and 7 as 1-(3-nitropyridin-2-yl)piperazine derivatives were radiolabeled with fac-[(99m)Tc(CO)(3)(H(2)O)(3)](+) and (99m)Tc(CO)(3)-[6] and (99m)Tc(CO)(3)-[7] were obtained with high radiochemical purity (RCP > 94%). ...
METHODS: Compounds 6 and 7 as 1-(3-nitropyridin-2-yl)piperazine derivatives were radiolabeled with fac-[(99m)Tc(CO)(3)(H(2)O)(3)](+) …
Scaling advantage over path-integral Monte Carlo in quantum simulation of geometrically frustrated magnets.
King AD, Raymond J, Lanting T, Isakov SV, Mohseni M, Poulin-Lamarre G, Ejtemaee S, Bernoudy W, Ozfidan I, Smirnov AY, Reis M, Altomare F, Babcock M, Baron C, Berkley AJ, Boothby K, Bunyk PI, Christiani H, Enderud C, Evert B, Harris R, Hoskinson E, Huang S, Jooya K, Khodabandelou A, Ladizinsky N, Li R, Lott PA, MacDonald AJR, Marsden D, Marsden G, Medina T, Molavi R, Neufeld R, Norouzpour M, Oh T, Pavlov I, Perminov I, Prescott T, Rich C, Sato Y, Sheldan B, Sterling G, Swenson LJ, Tsai N, Volkmann MH, Whittaker JD, Wilkinson W, Yao J, Neven H, Hilton JP, Ladizinsky E, Johnson MW, Amin MH. King AD, et al. Nat Commun. 2021 Feb 18;12(1):1113. doi: 10.1038/s41467-021-20901-5. Nat Commun. 2021. PMID: 33602927 Free PMC article.
Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
Molavi O, Narimani F, Asiaee F, Sharifi S, Tarhriz V, Shayanfar A, Hejazi M, Lai R. Molavi O, et al. Pharm Biol. 2017 Dec;55(1):729-739. doi: 10.1080/13880209.2016.1270972. Pharm Biol. 2017. PMID: 28027688 Free PMC article.
MATERIALS AND METHODS: The cells were treated with silibinin (at 50 to 600 muM concentrations) and/or chemo drugs for 24 and 48 h, then cell viability and changes in oncogenic proteins were determined by MTT assay and Western blotting/RT-PCR, respectively. ...Interestingly …
MATERIALS AND METHODS: The cells were treated with silibinin (at 50 to 600 muM concentrations) and/or chemo drugs for 24 and 48 h, th …
33 results